Rebecca Byam, CFO of HCW Biologics Inc. ($HCWB), made two open market purchases totaling about $220,000 in the last year, with the most recent on May 8, 2025. Her buying activity ranks 1,459th among 4,983 insiders in our database, where the average is $1.46 million across 3.29 transactions. She reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2025 | HCW Biologics Inc. | $HCWB | Byam Rebecca | Chief Financial Officer | P | Common Stock | 8462 | $26.00 | 43,010.0000 | 44,934,120 | 24.49% | 0.02% |
| May 7, 2025 | HCW Biologics Inc. | $HCWB | Byam Rebecca | Chief Financial Officer | P | Common Stock Purchase Warrant | 4231 | $0.00 | 4,231.0000 | 44,934,120 | 9999.99% | 0.01% |
| Feb. 20, 2024 | HCW Biologics Inc. | $HCWB | Byam Rebecca | Chief Financial Officer | A | Common Stock | 760714 | $1.40 | 1,381,909.0000 | 0 | 122.46% | 0.00% |